Cleveland Clinic Cancer Advances
New Cell Therapies May Hold Key to Treatment of Advanced and Rare Skin Cancers
20 Jan 2022
Brian Gastman, MD, Surgical and Co-Director of Cleveland Clinic’s Melanoma and High-Risk Skin Cancer Program joins the Cancer Advances podcast to discuss Merkel cell carcinoma (MCC). Listen as Dr. Gastman discusses clinical trials exploring the use of immunotherapy with adoptive cell transfer for advanced melanoma and Merkel cell carcinoma.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast